Stroke News

Adults who eat more foods associated with a Mediterranean diet have lower blood pressure, BMI and reduced cardiovascular risk, according to study findings published in Nutrition, Metabolism & Cardiovascular Diseases.

PHILADELPHIA — Among patients with advanced HF requiring a left ventricular assist device, measures of cerebrovascular blood flow improved significantly after device implant, a speaker reported.

Black women in the U.S. who reported experiencing interpersonal racism in employment, housing and police interactions had increased stroke risks, according to findings published in JAMA Network Open.

PHILADELPHIA — Among patients hospitalized with atrial fibrillation discharged on a direct oral anticoagulant, more than 10% received an off-label dose, researchers reported at the American Heart Association Scientific Sessions.

PHILADELPHIA — Two observational studies presented at the American Heart Association Scientific Sessions linked regular marijuana use to elevated risk for HF and elevated risk for major adverse cardiac and cerebrovascular events.

PHILADELPHIA — In a phase 2b trial, abelacimab, a novel factor XI inhibitor, drastically reduced bleeding compared with rivaroxaban in patients with atrial fibrillation requiring stroke prevention.

PHILADELPHIA — In patients with subclinical atrial fibrillation, apixaban lowered risk for stroke but increased risk for bleeding compared with aspirin, according to the results of the ARTESIA trial.

The Healio team is providing live coverage of the American Heart Association's Scientific Sessions in Philadelphia.

The FDA approved the enzyme replacement therapy Adzynma for the prophylactic or on-demand treatment of adults and pediatric patients with congenital thrombotic thrombocytopenic purpura, a rare blood clotting disorder.

An integrated carotid artery stent system was associated with the lowest 1-year event rates in any well-powered, multicenter carotid revascularization trial, according to data presented at VIVA.23.